Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus
Clinical trial NCT04069949 · UNKNOWN
Trial details
- NCT number
- NCT04069949
- Sponsor
- Sichuan University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2020-10-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.